Abstract:Yu-Cheng Zhang, 1, 2, &ast Yu-Xia Yang, 2, 3, &ast Yu Liu, 4 Xi-Jian Liu, 5 Ji-Hang Dai, 2 Rang-Shan Gao, 2 Yang-Yang Hu, 2 Wen-Yong Fei 2 1 Clinical Medical College, Dalian Medical University, Dalian, 116044, People's Republic of China; 2 Department of Orthopedics and Sports Medicine, Northern Jiangsu People's Hospital, Affiliated to Yangzhou University, Yangzhou, 225001, People's Republic of China; 3 Clinical Medical College, Yangzhou University, Yangzhou, 225001, People's Republic of China; 4 Department of Orthopedics, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, 214062, People's Republic of China; 5 School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, 201620, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yu Liu, Department of Orthopedics, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, 214062, People's Republic of China, Email Wen-Yong Fei, Department of Orthopedics and Sports medicine, Northern Jiangsu People's Hospital, Yangzhou, 225001, People's Republic of China, Tel +86 180 5106 1779, Email Background: Volumetric Muscle Loss (VML) denotes the traumatic loss of skeletal muscle, a condition that can result in chronic functional impairment and even disability. While the body can naturally repair injured skeletal muscle within a limited scope, patients experiencing local and severe muscle loss due to VML surpass the compensatory capacity of the muscle itself. Currently, clinical treatments for VML are constrained and demonstrate minimal efficacy. Selenium, a recognized antioxidant, plays a crucial role in regulating cell differentiation, anti-inflammatory responses, and various other physiological functions. Methods: We engineered a porous Se@SiO 2 nanocomposite (SeNPs) with the purpose of releasing selenium continuously and gradually. This nanocomposite was subsequently combined with a decellularized extracellular matrix (dECM) to explore their collaborative protective and stimulatory effects on the myogenic differentiation of adipose-derived mesenchymal stem cells (ADSCs). The influence of dECM and NPs on the myogenic level, reactive oxygen species (ROS) production, and mitochondrial respiratory chain (MRC) activity of ADSCs was evaluated using Western Blot, ELISA, and Immunofluorescence assay. Results: Our findings demonstrate that the concurrent application of SeNPs and dECM effectively mitigates the apoptosis and intracellular ROS levels in ADSCs. Furthermore, the combination of dECM with SeNPs significantly upregulated the expression of key myogenic markers, including MYOD, MYOG, Desmin, and myosin heavy chain in ADSCs. Notably, this combination also led to an increase in both the number of mitochondria and the respiratory chain activity in ADSCs. Conclusion: The concurrent application of SeNPs and dECM effectively diminishes ROS production, boosts mitochondrial function, and stimulates the myogenic differentiation of ADSCs. This study lays the groundwork for future treatments of VML utilizing the combination of SeNPs and dECM. Keywords: porous Se@SiO 2 nanocomposite, SeNPs, adipose-derived mesenchymal stem cells, ADSCs, decellularized extracellular matrix, dECM, myogenic differentiation, mitochondria Graphical As a crucial component of the human motor system, skeletal muscle possesses a regenerative capacity to a certain extent, capable of repair and regeneration after minor injuries. However, in specific scenarios resulting in severe muscle loss, such as volumetric muscle defects (VML), the extent of muscle loss surpasses the compensatory abilities of local stem cells and extracellular matrix (ECM). This frequently leads to impairment of limb function and permanent disability, imposing a substantial burden on both society and families. 1 Currently, effective treatments for VML remain limited. While free skeletal muscle transplantation is a common clinical approach, its success is often hindered by a shortage of donors, and graft may not fully regenerate functional tissue. 2 In recent years, skeletal muscle tissue engineering (SMTE) has become a potential alternative to traditional VML surgery in regenerative medicine. 3 Decellularized extracellular matrix (dECM) is a biomaterial obtained through physical or chemical means to eliminate cellular components while retaining extracellular matrix components. 4 dECM comprises proteins, glycosaminoglycans, proteoglycans, and various other matrix components presen -Abstract Truncated-

Perfusable adipose decellularized extracellular matrix biological scaffold co-recellularized with adipose-derived stem cells and L6 promotes functional skeletal muscle regeneration following volumetric muscle loss

A Myogenic Niche with a Proper Mechanical Stress Environment Improves Abdominal Wall Muscle Repair by Modulating Immunity and Preventing Fibrosis.

Preparation of Decellularized Biphasic Hierarchical Myotendinous Junction Extracellular Matrix for Muscle Regeneration.

Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration

Scalable macroporous hydrogels enhance stem cell treatment of volumetric muscle loss

Implantation of Decellularized Extracellular Matrix with Resistance Training Effectively Repairs a Volumetric Muscle Loss

Bioinspired electrospun decellularized extracellular matrix scaffolds promote muscle regeneration in a rat skeletal muscle defect model

Muscle-Specific ECM Fibers Made with Anchored Cell Sheet Engineering Support Tissue Regeneration in Rat Models of Volumetric Muscle Loss

Decellularized Tissue for Muscle Regeneration

Combining Porous Se@SiO2 Nanocomposites and dECM Enhances the Myogenic Differentiation of Adipose-Derived Stem Cells

Mesenchymal Stem Cells and Extracellular Matrix Scaffold Promote Muscle Regeneration by Synergistically Regulating Macrophage Polarization Toward the M2 Phenotype.

Perfusion-decellularized Skeletal Muscle As a Three-Dimensional Scaffold with a Vascular Network Template.

Melatonin‐Based and Biomimetic Scaffold as Muscle–ECM Implant for Guiding Myogenic Differentiation of Volumetric Muscle Loss

Decellularized Muscle Supports New Muscle Fibers and Improves Function Following Volumetric Injury

Preferred M2 Polarization by ASC-Based Hydrogel Accelerated Angiogenesis and Myogenesis in Volumetric Muscle Loss Rats

Cells, scaffolds, and bioactive factors: Engineering strategies for improving regeneration following volumetric muscle loss

Novel muscle-derived extracellular matrix hydrogel promotes angiogenesis and neurogenesis in volumetric muscle loss

Adipogenic-Myogenic Signaling in Engineered Human Muscle Grafts used to Treat Volumetric Muscle Loss

Harnessing the synergy of perfusable muscle flap matrix and adipose-derived stem cells for prevascularization and macrophage polarization to reconstruct volumetric muscle loss

Biomimetic glycosaminoglycan-based scaffolds improve skeletal muscle regeneration in a Murine volumetric muscle loss model

Rehabilitative exercise and spatially patterned nanofibrillar scaffolds enhance vascularization and innervation following volumetric muscle loss